2024
Anxiety and fear of cancer recurrence as predictors of subsequent pain interference in early cancer survivorship: Exploring the moderating roles of cognitive and emotional factors
Gnall K, Emrich M, Magin Z, Park C, Bellizzi K, Sanft T. Anxiety and fear of cancer recurrence as predictors of subsequent pain interference in early cancer survivorship: Exploring the moderating roles of cognitive and emotional factors. Journal Of Behavioral Medicine 2024, 47: 980-993. PMID: 39110352, DOI: 10.1007/s10865-024-00506-1.Peer-Reviewed Original ResearchFear of cancer recurrencePain interferenceCancer survivorsAssociated with greater pain interferenceGreater pain interferencePrimary cancer treatmentCancer recurrenceQuality of lifeCancer survivorshipLonger-term painSelf-report measuresEmotion regulation difficultiesCancer treatmentConsequence beliefsChronic beliefsCognitive/emotional factorsPsychological treatmentLongitudinal studyPotential moderatorsAnxietyRegulation difficultiesPainFollow-upEmotional factorsSurvivors
2023
Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR +) breast cancer
Foldi J, Tsagianni A, Salganik M, Schnabel C, Brufsky A, van Londen G, Pusztai L, Sanft T. Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR +) breast cancer. BMC Cancer 2023, 23: 606. PMID: 37391697, PMCID: PMC10314405, DOI: 10.1186/s12885-023-11104-w.Peer-Reviewed Original ResearchConceptsAdjuvant endocrine therapyEarly-stage hormone receptor-positive breast cancerHormone receptor-positive breast cancerReceptor-positive breast cancerEndocrine therapyBreast cancerLate breast cancer recurrenceExtended endocrine therapyNon-persistence ratesIntolerable side effectsBone density scanBreast cancer recurrenceHigher likelihoodRate of persistenceElectronic health recordsConclusionsIn patientsMedication persistenceTreatment persistenceLow patientsMetastatic recurrenceCancer recurrenceCommon reasonSide effectsPatientsStage I